The ọgwụ 'Warfarin'. Ntuziaka maka ojiji

Ọgwụ "Warfarin" ntuziaka maka ojiji na-ezo aka na udi nke anticoagulants nke anọ ihe. The ọgwụ na-enwe ike ibelata ihe njikọ nke clotting ihe (vitamin K-ndabere) nakwa dị ka protein C na S na imeju. Ezigbo anticoagulant mmetụta hụrụ na nke atọ ma ọ bụ ise mgbe ihe mmalite nke ọgwụ ma kwụsị mgbe atọ ka ụbọchị ise mgbe ikpeazụ dose. The ọgwụ dị na mbadamba ụdị.

Ọ na-atụ aro mgbe na-ewere ọgwụ na "Warfarin" nri na-agụnye ịnọgide na-enwe ihe dị ka otu ego nke vitamin K na ihe oriri

na-agba akaebe

The ọgwụ na-owụt maka igbochi na ọgwụgwọ nke thrombosis na thromboembolism. Site na-egosi maka ọgwụ "Warfarin" ntụziaka ntuziaka na-akọ thromboembolism na nnukwu venous thrombosis, akpa ume embolism, nlọghachite nke myocardial infarction, postoperative thrombosis. The nkwadebe na-kenyere mejuputa atumatu thromboembolic mwepụ ma ọ bụ ịwa ahụ thrombosis (ka ihe ndị ọzọ n'aka) maka atrial fibrillation (eletriki cardioversion), relapsing (re) akwara thrombosis, embolism na akpa ume akwara. Pụtara "Warfarin" ntụziaka ntuziaka na-atụ aro na vaskụla prosthetics na obi valves (nke a na-ekwe na-achọkwa iji nke acetylsalicylic acid). Ọzọkwa, ọgwụ na-kenyere thrombosis, ọrịa ụbụrụ, akwara na elu akwara, nakwa dị ka nke abụọ mgbochi nke thrombosis ma ọ bụ embolism n'oge ntabi atrial ma ọ bụ mgbe infarction.

Contraindications ọgwụ "Warfarin" ntụziaka ntuziaka classifies onye ekweghị ibe nọrọ, gbasara akụrụ ma ọ bụ hepatic ọrịa oké ike, nnukwu hemorrhage, ọbara mgbali (arọ uwa), exacerbation nke ọnyá na afo ma ọ bụ duodenum, hemorrhagic diathesis, enweghị S na C na-edozi, aṅụrụma, ọrịa ụbụrụ hemorrhage, gbasara akụrụ ọrụ insufficiency, nnukwu DIC, thrombocytopenia. Inye a ọgwụ n'oge ime.

The kasị oghom ihe n'oge ochichi nke ọgwụ ọjọọ, "Warfarin" na-agba ọbara. Na obere okwu, e nwere necrosis nke anụ, mụbara imeju enzymes, afọ ọsịsa, eczema, ntutu isi ọnwụ, vasculitis.

onunu ogwu

The ọgwụ na-owụt maka onu ochichi. Na-atụ aro otu ngwa, na n'otu oge ahụ. The mbụ dose - abụọ na ọkara ise milligrams kwa ụbọchị.

Ụdi dosing Usoro "Warfarin" (INR ma ọ bụ prothrombin oge mgbe a na-sonye na akaụntụ) kpebisiri ike n'otu n'otu. Na abụọ anọ ugboro si iyi ga- ụba prothrombin oge. Na nke a na-INR (mba normalized ruru) kwesịrị iru (dabere daa ọrịa gbasara nke puru omume agba ọbara, thrombosis ize ndụ) 2.2-4.4.

Agadi ọrịa ma ọ bụ na a ebelatawo ọnọdụ kenyere ala doses nke ọgwụ "Warfarin".

Tupu na-eru nso na ime (na ikpe nke pụrụ ịrịa mmepe nke thromboembolic nsogbu) ọgwụ amalite abụọ ma ọ bụ ụbọchị atọ tupu aka.

Na nnukwu thrombosis ọgwụgwọ a rụrụ na Nchikota na ọgwụ "Heparin" ruo mgbe oge mgbe anticoagulant mmetụta bụ n'ụzọ zuru ezu na-egosipụta (na-emekarị bụghị tupu atọ na ise).

Na oge nke ọgwụ na-adabere na ọrịa na-arịa.

Tupu mmalite nke ọgwụgwọ dị mkpa iji chọpụta ihe INR index (na dị na prothrombin oge, nyere uche ọnụọgụ thromboplastin).

Dị ka ọtụtụ ndị ọrịa, ọgwụ "Warfarin" abụghị naanị irè, ma adaba, ebe ọ bụ na ọ chọrọ ka a nanị otu ugboro n'ụbọchị. Ke adianade do, pụtara na-ọma na-anabata, mmetụta dị ụkọ. Otú ọ dị, n'ihu iji ngwaahịa, ị kwesịrị ị na ịkpọ a ọkachamara, ma na-agụ ntụziaka ọma.